FIELD: medicine; pharmaceutics.
SUBSTANCE: present invention relates to a method of treating schizophrenia using pharmaceutical compositions containing a compound of formula (I), which are suitable for intramuscular delivery of neuroleptics using high injection rates.
EFFECT: implementation of the purpose is provided.
9 cl, 6 dwg, 7 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
ARIPIPRAZOLE PREPARATIONS HAVING HIGH INJECTION RATES | 2015 |
|
RU2688233C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING WATER-INSOLUBLE ANTIPSYCHOTIC DRUG AND SORBITAN ESTERS | 2012 |
|
RU2757859C2 |
PHARMACEUTICAL COMPOSITIONS COMPRISING WATER-INSOLUBLE ANTIPSYCHOTIC AGENT AND SORBITAN ESTERS | 2012 |
|
RU2627469C2 |
ARIPIPRAZOLE PRODRUG COMPOSITIONS | 2015 |
|
RU2817019C2 |
ARIPIPRAZOLE PRODRUG COMPOSITIONS | 2015 |
|
RU2705376C2 |
POLYVALENT VACCINE AGAINST INFLUENZA BASED ON NANOPARTICLES | 2019 |
|
RU2805552C2 |
EMULSIONS OR MICROEMULSIONS FOR USE IN ENDOSCOPIC MUCOSAL RESECTIONING AND/OR ENDOSCOPIC SUBMUCOSAL DISSECTION | 2014 |
|
RU2676278C1 |
PRE-FILLED PLASTIC SYRINGE CONTAINING VEGF ANTAGONIST | 2015 |
|
RU2702748C2 |
LIQUID COMPOSITIONS OF PROTEINS CONTAINING AGENTS FOR VISCOSITY REDUCTION | 2014 |
|
RU2710542C2 |
LIQUID PROTEIN COMPOSITIONS CONTAINING VISCOSITY-REDUCING AGENTS | 2014 |
|
RU2782765C2 |
Authors
Dates
2024-05-22—Published
2015-03-19—Filed